Chris Mansi
Co-Founder and CEO @ Viz
San Francisco, United States
Chris Mansi is a Series A investor at Viz in San Francisco focused on Health Care and Medical. Chris Mansi is based out of San Francisco, California and is the Co-Founder,CEO, and Board Member of Viz. Chris previously worked at EDUSURG LTD as a CEO. Chris Mansi attended the University of Cambridge.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Chris Mansi invests in
Stages Chris Mansi invests in
Countries Chris Mansi invests in
Round sizes
Round size
- Series A
- $12M–$25M
Investment Focus
Industry
- Health Care 3 (60%)
- Medical 1 (20%)
- Oncology 1 (20%)
- Software 1 (20%)
- Wellness 1 (20%)
Stage
- Series A 3 (60%)
- Seed 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- United States 2 (40%)
- Israel 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NeuraLight
|
NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care. | $25M / Series A / May 24, 2022 | |
|
NeuraLight
|
NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care. | $25M / Seed / May 24, 2022 | |
Canopy
|
Canopy provides oncology practices with a comprehensive platform for all the care that happens between visits. Canopy’s multi-channel ePRO and remote triage system enable practices to identify and prioritize patients who need help, resolve their issues using intelligent software, and generate new reimbursement streams from high-quality care. Formore information, visit www.canopycare.us. | $13M / Series A / Mar 17, 2022 | |
|
Canopy
|
Canopy provides oncology practices with a comprehensive platform for all the care that happens between visits. Canopy’s multi-channel ePRO and remote triage system enable practices to identify and prioritize patients who need help, resolve their issues using intelligent software, and generate new reimbursement streams from high-quality care. Formore information, visit www.canopycare.us. | $18M / Venture - Series Unknown / Mar 17, 2022 | |
HumanFirst
|
HumanFirst accelerates the adoption of patient-centered clinical trials using precision digital measures (e.g., digital biomarkers and eCOA).At HumanFirst, we offer a precision measures platform - the world’s largest AI-powered SaaS platform trusted to improve human outcomes. We provide insights, intelligence, and accuracy with validated evidencedata to precisely guide and accelerate human-centric drug development. Twenty-two of the 25 largest pharmaceutical companies in the world have used the HumanFirst platform to evaluate and enable the deployment of digital health technologies (DHTs). | $12M / Series A / May 31, 2021 |
Co-Investors
About Viz
Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat them. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularlydisabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes.Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce the time to treatment and improve access to care.Viz was founded in 2016 and is based in San Francisco, California.
Viz Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Mike Herring
Chief Financial Officer
|
|||
Brian Davis
DevOps & Network Engineer
|
|||
|
Chris Mansi
Co-Founder and CEO
|
|||
Conrad Yiu
CSO
|
|||
David Kizner
General Counsel and Chief Privacy Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Chris Mansi invest in?
Chris Mansi invests primarily in Health Care, Medical and Oncology startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Chris Mansi's check size?
Chris Mansi typically joins rounds of $12M–$25M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chris Mansi participates in.
When did Chris Mansi last invest?
The most recent investment recorded for Chris Mansi closed in May 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
